Jo DG - Search Results

1

Stem Cell-Derived Extracellular Vesicle-Bearing Dermal Filler Ameliorates the Dermis Microenvironment by Supporting CD301b-Expressing Macrophages.

You DG, An JY, Um W, Jung JM, Oh BH, Nguyen VQ, Jeon J, Lee J, Jo DG, Cho YW, Park JH. You DG, et al. Among authors: jo dg. ACS Nano. 2022 Jan 25;16(1):251-260. doi: 10.1021/acsnano.1c06096. Epub 2021 Dec 27. ACS Nano. 2022. PMID: 34957822

2

Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis.

Kim YJ, Chae SY, Jin CH, Sivasubramanian M, Son S, Choi KY, Jo DG, Kim K, Chan Kwon I, Lee KC, Park JH. Kim YJ, et al. Among authors: jo dg. Biomaterials. 2010 Dec;31(34):9057-64. doi: 10.1016/j.biomaterials.2010.08.015. Biomaterials. 2010. PMID: 20813405

3

Self-assembled dextran sulphate nanoparticles for targeting rheumatoid arthritis.

Kim SH, Kim JH, You DG, Saravanakumar G, Yoon HY, Choi KY, Thambi T, Deepagan VG, Jo DG, Park JH. Kim SH, et al. Among authors: jo dg. Chem Commun (Camb). 2013 Nov 14;49(88):10349-51. doi: 10.1039/c3cc44260h. Chem Commun (Camb). 2013. PMID: 23942894

4

Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery.

Thambi T, Deepagan VG, Yoon HY, Han HS, Kim SH, Son S, Jo DG, Ahn CH, Suh YD, Kim K, Kwon IC, Lee DS, Park JH. Thambi T, et al. Among authors: jo dg. Biomaterials. 2014 Feb;35(5):1735-43. doi: 10.1016/j.biomaterials.2013.11.022. Epub 2013 Nov 26. Biomaterials. 2014. PMID: 24290696

5

A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis.

Shin JM, Kim SH, Thambi T, You DG, Jeon J, Lee JO, Chung BY, Jo DG, Park JH. Shin JM, et al. Among authors: jo dg. Chem Commun (Camb). 2014 Jul 21;50(57):7632-5. doi: 10.1039/c4cc02595d. Chem Commun (Camb). 2014. PMID: 24893961

6

Hyaluronan nanoparticles bearing γ-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis.

Heo R, Park JS, Jang HJ, Kim SH, Shin JM, Suh YD, Jeong JH, Jo DG, Park JH. Heo R, et al. Among authors: jo dg. J Control Release. 2014 Oct 28;192:295-300. doi: 10.1016/j.jconrel.2014.07.057. Epub 2014 Aug 7. J Control Release. 2014. PMID: 25109660

7

Pin1 promotes neuronal death in stroke by stabilizing Notch intracellular domain.

Baik SH, Fane M, Park JH, Cheng YL, Yang-Wei Fann D, Yun UJ, Choi Y, Park JS, Chai BH, Park JS, Back SH, Jeong JI, Jang YJ, Bahn G, Lee JY, Li YI, Sobey CG, Uchida T, Park JH, Kim HT, Tang SC, Arumugam TV, Jo DG. Baik SH, et al. Among authors: jo dg. Ann Neurol. 2015 Mar;77(3):504-16. doi: 10.1002/ana.24347. Epub 2015 Feb 3. Ann Neurol. 2015. PMID: 25558977

8

Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.

Han HS, Thambi T, Choi KY, Son S, Ko H, Lee MC, Jo DG, Chae YS, Kang YM, Lee JY, Park JH. Han HS, et al. Among authors: jo dg. Biomacromolecules. 2015 Feb 9;16(2):447-56. doi: 10.1021/bm5017755. Epub 2015 Jan 7. Biomacromolecules. 2015. PMID: 25565417

9

Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy.

Kim MJ, Park JS, Lee SJ, Jang J, Park JS, Back SH, Bahn G, Park JH, Kang YM, Kim SH, Kwon IC, Jo DG, Kim K. Kim MJ, et al. Among authors: jo dg. J Control Release. 2015 Oct 28;216:140-8. doi: 10.1016/j.jconrel.2015.08.025. Epub 2015 Aug 14. J Control Release. 2015. PMID: 26282098

10

Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment.

Rao NV, Yoon HY, Han HS, Ko H, Son S, Lee M, Lee H, Jo DG, Kang YM, Park JH. Rao NV, et al. Among authors: jo dg. Expert Opin Drug Deliv. 2016;13(2):239-52. doi: 10.1517/17425247.2016.1112374. Epub 2015 Dec 14. Expert Opin Drug Deliv. 2016. PMID: 26653872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page